Drug Profile
Research programme: ion trap technology based therapeutics - ZS Pharma
Alternative Names: Non absorbed binders - ZS PharmaLatest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator ZS Pharma
- Class Minerals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cardiovascular disorders; Kidney disorders; Liver disorders; Metabolic disorders
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for research development in Cardiovascular-disorders in USA
- 28 Sep 2018 No recent reports of development identified for research development in Kidney-disorders in USA
- 28 Sep 2018 No recent reports of development identified for research development in Liver-disorders in USA